Additional file 1 of Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ...

Additional file 1. Supplementary Table S1. List of Rx-Risk-V comorbidity categories with corresponding medicine groups and Anatomical Therapeutic Chemical (ATC), and ATC codes of medications dispensed to patients included in the Opera-C study. Supplementary Table 2. Prevalence of comorbidity categor...

Full description

Bibliographic Details
Main Authors: Clark, Paul J., Valery, Patricia C., Ward, James, Strasser, Simone I., Weltman, Martin, Thompson, Alexander, Levy, Miriam T., Leggett, Barbara, Zekry, Amany, Rong, Julian, Angus, Peter, George, Jacob, Bollipo, Steven, McGarity, Bruce, Sievert, William, Macquillan, Gerry, Tse, Edmund, Nicoll, Amanda, Wade, Amanda, Chu, Geoff, Harding, Damian, Cheng, Wendy, Farrell, Geoff, Roberts, Stuart K.
Format: Text
Language:unknown
Published: figshare 2022
Subjects:
Medicine
Science Policy
Mental Health
Infectious Diseases
FOS Health sciences
First Nations
Online Access:https://dx.doi.org/10.6084/m9.figshare.20296534
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Hepatitis_C_treatment_outcomes_for_Australian_First_Nations_Peoples_equivalent_SVR_rate_but_higher_rates_of_loss_to_follow-up/20296534
Description
Summary:Additional file 1. Supplementary Table S1. List of Rx-Risk-V comorbidity categories with corresponding medicine groups and Anatomical Therapeutic Chemical (ATC), and ATC codes of medications dispensed to patients included in the Opera-C study. Supplementary Table 2. Prevalence of comorbidity categories included in the Rx-Risk-V according for First Nations Peoples and non-Indigenous Australians. Supplementary Table 3. Logistic regression analysis of factors associated with loss to follow-up among First Nations Peoples. ...

Similar Items